Howard Rosen
Directeur/Membre du Conseil chez KALA BIO, INC.
Fortune : 7 547 $ au 30/04/2024
Profil
Howard B.
Rosen is currently an Independent Director at KALA BIO, Inc. He also holds director positions at Hammerton, Inc., Entrega, Inc., The Mit Club of Northern California, Hopewell Therapeutics, Inc., and the National Academy of Engineering.
Previously, Mr. Rosen served as the President & Chief Executive Officer of Pearl Therapeutics, Inc. from 2010 to 2011.
He was also the Chairman of Alcobra Ltd.
from 2014 to 2017.
Additionally, he held director positions at Pharsight Corp.
from 2004 to 2008, Emergent Travel Health, Inc. from 2007 to 2015, and GenPharm International LLC from 1989 to 1993.
Mr. Rosen has an educational background from Stanford University, where he completed his undergraduate studies.
He also attended the Massachusetts Institute of Technology for graduate studies and obtained an MBA from the Stanford Graduate School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TALPHERA, INC.
0,03% | 10/10/2023 | 5 293 ( 0,03% ) | 5 928 $ | 30/04/2024 |
KALA BIO, INC.
0,01% | 01/04/2024 | 262 ( 0,01% ) | 1 619 $ | 30/04/2024 |
Postes actifs de Howard Rosen
| Sociétés | Poste | Début |
|---|---|---|
| KALA BIO, INC. | Directeur/Membre du Conseil | 14/05/2015 |
Hopewell Therapeutics, Inc.
 Hopewell Therapeutics, Inc. BiotechnologyHealth Technology Hopewell Therapeutics, Inc. is a company that is focused on discovering, synthesizing, and developing tissue-targeted lipid nanoparticles (TTLNPs) to bring genomic medicines to patients. The company is based in Woburn, MA and was founded in 2018 by Qiaobing Xu. Hopewell is pursuing opportunities to redefine the non-viral delivery space for novel genomic medicines by designing systemically administered LNPs to specifically target extrahepatic tissues and cells throughout the body. The company has built a robust intellectual property portfolio with an expansive library of ionizable lipids and has established partnerships with several industry-leading companies. Hopewell is developing its own internal pipeline, initially targeting diseases of the lung, while concurrently exploring the potential of its TTLNP platform for patients with unmet needs in oncology, infectious diseases, rare genetic diseases, and neurological disorders. Louis Brenner has been the CEO of the company since 2022. | Directeur/Membre du Conseil | - |
Hammerton, Inc.
 Hammerton, Inc. Electrical ProductsProducer Manufacturing Hammerton, Inc. is a company that specializes in designing and crafting American-made lighting fixtures. The private company is based in Salt Lake City, UT. With over 25 years of experience, the company has become a leader in custom lighting design, engineering, and manufacturing. The company's team of 150 employees has created lighting fixtures for various establishments, including hotels, restaurants, luxury resorts, corporate headquarters, private clubs, and residences worldwide. | Directeur/Membre du Conseil | - |
The Mit Club of Northern California
 The Mit Club of Northern California Miscellaneous Commercial ServicesCommercial Services The Mit Club of Northern California is a regional alumni club of Massachusetts Institute of Technology. The non-profit company is based in Northern California. The club is run by volunteer MIT alums and organizes around one hundred events every year, serving over 15,000 alumni. The club promotes design and innovation through an interdisciplinary approach, with emphasis on collaborative exploration and problem solving. | Directeur/Membre du Conseil | - |
Entrega, Inc.
 Entrega, Inc. Pharmaceuticals: MajorHealth Technology Entrega, Inc. develops oral drug delivery technologies. The firm’s platform enables novel applications in a variety of fields, such as disease management and tracking in the burgeoning mobile health arena. Its proprietary technology seeks to solve the oral delivery problem with an engineering solution that protects the payload and delivers biological molecules, drug substances and nanoparticles. The company was founded by Samir Mitragotri in 2010 and is headquartered in Boston, MA. | Directeur/Membre du Conseil | - |
National Academy of Engineering
 National Academy of Engineering Miscellaneous Commercial ServicesCommercial Services Part of The National Academies of Science, the National Academy of Engineering operates as a professional membership organization. The company is based in Washington. | Corporate Officer/Principal | - |
Anciens postes connus de Howard Rosen
| Sociétés | Poste | Fin |
|---|---|---|
| TALPHERA, INC. | Directeur Général | 05/03/2017 |
Aria Pharmaceuticals, Inc.
 Aria Pharmaceuticals, Inc. Drugstore ChainsRetail Trade twoXAR, Inc. provides drug discovery services. Its DUMA platform rapidly evaluates massive public and proprietary datasets to identify and rank probability drug-disease matches. The company was founded by Andrew A. Radin and Andrew M. Radin in 2014 and is headquartered in Palo Alto, CA. | Directeur/Membre du Conseil | 01/01/2023 |
Metera Pharmaceuticals, Inc.
 Metera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Metera Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is headquartered in Newton, MA. | Directeur/Membre du Conseil | 01/01/2020 |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Howard Rosen
| Stanford University | Undergraduate Degree |
| Massachusetts Institute of Technology | Graduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| KALA BIO, INC. | Health Technology |
| TALPHERA, INC. | Health Technology |
| Entreprise privées | 20 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Pharsight Corp.
 Pharsight Corp. Packaged SoftwareTechnology Services Pharsight's products and services help drugmakers build and shape their pipelines and decrease time and money spent on development. Using computer simulation, statistics, and data analysis along with pharmacology, disease and drug modeling, genetics, and databases of biologic information, Pharsight helps clients determine drug-development targets. | Technology Services |
CoTherix, Inc.
 CoTherix, Inc. Pharmaceuticals: MajorHealth Technology CoTherix, Inc. develops therapeutic products. Its ventavis product is a nebulizer delivered therapy for pulmonary artery hypertension, which restricts blood flow to the lungs. CoTherix markets its products in the US, Europe, and Australia. The company was founded in February, 2000 by Donald J. Santel and Gerard Turino and is located in Brisbane, CA. | Health Technology |
Emergent Travel Health, Inc.
 Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Technology Services |
CNS Therapeutics, Inc.
 CNS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology CNS Therapeutics, Inc. develops and manufactures drug delivery products. The company was founded in 2007 and is headquartered in St. Paul, MN. | Health Technology |
Aldea Pharmaceuticals, Inc.
 Aldea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aldea Pharmaceuticals, Inc. develops novel enzyme activators to enhance the removal of toxic aldehydes. It targets Aldehyde metabolism dysfunction which is associated with a variety of diseases from acute alcohol toxicity to orphan indications such as Fanconi anemia. The company was founded by Daria Mochly-Rosen, Che-Hong Chen and Wenjin Yang in 2011 and is headquartered in Redwood City, CA. | Health Technology |
Alcobra Ltd.
 Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel. | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
GenPharm International LLC
 GenPharm International LLC BiotechnologyHealth Technology GenPharm International, Inc. manufactures biopharmaceutical products. The company works towards the application of transgenic animal technology to the development of human antibody products, which are used for therapeutic uses. It was founded in 1988 and is located in San Jose, CA. | Health Technology |
Integral, Inc.
 Integral, Inc. Information Technology ServicesTechnology Services Integral, Inc. provides internet consulting and web development services. Its services include virtual private networking, network security, on-side service, troubleshooting and monitoring. The company was founded by Vadim Levy on November 4, 1998 and is headquartered in Montgomery Village, MD. | Technology Services |
National Academy of Engineering
National Academy of Engineering Miscellaneous Commercial ServicesCommercial Services Part of The National Academies of Science, the National Academy of Engineering operates as a professional membership organization. The company is based in Washington. | Commercial Services |
Pearl Therapeutics, Inc.
 Pearl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pearl Therapeutics, Inc. develops therapies for the treatment of chronic respiratory diseases. It offers respiratory product development, high quality therapies for COPD, Asthma and treatment and prevention of chronic respiratory diseases and asthma. The company was founded in 2006 by Sarvajna Dwivedi and is headquartered in Redwood City, CA. | Health Technology |
Hammerton, Inc.
Hammerton, Inc. Electrical ProductsProducer Manufacturing Hammerton, Inc. is a company that specializes in designing and crafting American-made lighting fixtures. The private company is based in Salt Lake City, UT. With over 25 years of experience, the company has become a leader in custom lighting design, engineering, and manufacturing. The company's team of 150 employees has created lighting fixtures for various establishments, including hotels, restaurants, luxury resorts, corporate headquarters, private clubs, and residences worldwide. | Producer Manufacturing |
Entrega, Inc.
Entrega, Inc. Pharmaceuticals: MajorHealth Technology Entrega, Inc. develops oral drug delivery technologies. The firm’s platform enables novel applications in a variety of fields, such as disease management and tracking in the burgeoning mobile health arena. Its proprietary technology seeks to solve the oral delivery problem with an engineering solution that protects the payload and delivers biological molecules, drug substances and nanoparticles. The company was founded by Samir Mitragotri in 2010 and is headquartered in Boston, MA. | Health Technology |
| NTF Therapeutics, Inc. | |
The Mit Club of Northern California
The Mit Club of Northern California Miscellaneous Commercial ServicesCommercial Services The Mit Club of Northern California is a regional alumni club of Massachusetts Institute of Technology. The non-profit company is based in Northern California. The club is run by volunteer MIT alums and organizes around one hundred events every year, serving over 15,000 alumni. The club promotes design and innovation through an interdisciplinary approach, with emphasis on collaborative exploration and problem solving. | Commercial Services |
Aria Pharmaceuticals, Inc.
Aria Pharmaceuticals, Inc. Drugstore ChainsRetail Trade twoXAR, Inc. provides drug discovery services. Its DUMA platform rapidly evaluates massive public and proprietary datasets to identify and rank probability drug-disease matches. The company was founded by Andrew A. Radin and Andrew M. Radin in 2014 and is headquartered in Palo Alto, CA. | Retail Trade |
Metera Pharmaceuticals, Inc.
Metera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Metera Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is headquartered in Newton, MA. | Health Technology |
Hopewell Therapeutics, Inc.
Hopewell Therapeutics, Inc. BiotechnologyHealth Technology Hopewell Therapeutics, Inc. is a company that is focused on discovering, synthesizing, and developing tissue-targeted lipid nanoparticles (TTLNPs) to bring genomic medicines to patients. The company is based in Woburn, MA and was founded in 2018 by Qiaobing Xu. Hopewell is pursuing opportunities to redefine the non-viral delivery space for novel genomic medicines by designing systemically administered LNPs to specifically target extrahepatic tissues and cells throughout the body. The company has built a robust intellectual property portfolio with an expansive library of ionizable lipids and has established partnerships with several industry-leading companies. Hopewell is developing its own internal pipeline, initially targeting diseases of the lung, while concurrently exploring the potential of its TTLNP platform for patients with unmet needs in oncology, infectious diseases, rare genetic diseases, and neurological disorders. Louis Brenner has been the CEO of the company since 2022. | Health Technology |
Firecyte Therapeutics, Inc.
 Firecyte Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Firecyte Therapeutics, Inc. is an emerging biotechnology company based in Cambridge, MA that is focused on developing novel treatment strategies for progressive neurodegenerative diseases of the eye. The company's research is centered around the role of microglia and neuroinflammation in these diseases. The team is led by Jonathan Levenson, the Chief Scientific Officer, who has over 16 years of experience in neuropsychiatry, neurodegeneration, and neuroinflammation. The company was founded by Dong Feng Chen and William E. Yelle, who has been the CEO since incorporation. | Commercial Services |